We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNBC
901
DELISTED
Sun Bancorp Inc
SNBC
$370K ﹤0.01%
22,029
– –
ADTN icon
902
Adtran
ADTN
$769M
$369K ﹤0.01%
+15,137
New +$390K
RSTI
903
DELISTED
Rofin-Sinar Technologies Inc
RSTI
$369K ﹤0.01%
15,428
– –
SBR
904
Sabine Royalty Trust
SBR
$1.06B
$368K ﹤0.01%
7,456
– –
OPEN
905
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
$366K ﹤0.01%
4,765
– –
SI
906
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$366K ﹤0.01%
2,716
-474
-15% -$62.2K
GEO icon
907
The GEO Group
GEO
$4.13B
$365K ﹤0.01%
17,003
– –
ALXN
908
DELISTED
Alexion Pharmaceuticals
ALXN
$365K ﹤0.01%
2,411
-64
-3% -$10.2K
ILMN icon
909
Illumina
ILMN
$28.7B
$364K ﹤0.01%
2,529
+2,000
+378% +$294K
VBK icon
910
Vanguard Small-Cap Growth ETF
VBK
$23.3B
$364K ﹤0.01%
2,943
+195
+7% +$24.2K
AAL icon
911
American Airlines Group
AAL
$9.9B
$363K ﹤0.01%
9,945
+7,700
+343% +$262K
HRB icon
912
H&R Block
HRB
$5.37B
$361K ﹤0.01%
12,000
– –
NI icon
913
NiSource
NI
$22B
$361K ﹤0.01%
25,962
– –
DDD icon
914
3D Systems Corp
DDD
$430M
$360K ﹤0.01%
6,106
+946
+18% +$70.6K
PBR.A icon
915
Petrobras Class A
PBR.A
$103B
$360K ﹤0.01%
26,014
+6,118
+31% +$75.4K
LUMN icon
916
Lumen
LUMN
$6.45B
$359K ﹤0.01%
10,957
-893
-8% -$27.3K
VCR icon
917
Vanguard Consumer Discretionary ETF
VCR
$5.92B
$359K ﹤0.01%
3,400
– –
LINE
918
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
$359K ﹤0.01%
12,700
-36,343
-74% -$1.15M
FOSL icon
919
Fossil Group
FOSL
$249M
$358K ﹤0.01%
3,090
-119
-4% -$13.9K
RYN icon
920
Rayonier
RYN
$6.52B
$357K ﹤0.01%
11,485
– –
RVP icon
921
Retractable Technologies
RVP
$20.1M
$356K ﹤0.01%
94,195
+10,866
+13% +$38.8K
NBIS
922
Nebius Group N.V.
NBIS
$47.7B
$355K ﹤0.01%
11,787
-17,634
-60% -$651K
SDRL
923
DELISTED
Seadrill Limited Common Stock
SDRL
$355K ﹤0.01%
38
+2
+6% +$19.7K
EWG icon
924
iShares MSCI Germany ETF
EWG
$1.55B
$354K ﹤0.01%
11,297
– –
HXL icon
925
Hexcel
HXL
$8.28B
$353K ﹤0.01%
8,126
+200
+3% +$8.73K
35 36
37
38 39

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.